According to court documents, defendants used a technology platform, management incentives, and clinical protocols that were designed together to corrupt medical decision-making at a national scale. Defendants sought to build a billion-dollar technology company and raise money from investors by advertising easy access to Adderall and other stimulants in exchange for payment of a monthly subscription fee:
Other ads deceived Americans who suffered from other mental health conditions — or simply from inattentiveness due to aging or a lack of structure due to work-from-home policies — into thinking that they were suffering from ADHD, and that Adderall was the solution to their problems.